Latisse PDF Print E-mail

Latisse - Image

Latisse LogoLATISSE (bimatoprost ophthalmic solution) 0.03%, approved by the U.S. Food and Drug Administration (FDA) in 2008, is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

Available only through a doctor, LATISSE is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE is required. If use of LATISSE is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).Call The Ferguson Clinic to see if LATISSE is right for you.

 

Our Services Include:

We look forward to helping with any of your aesthetic care needs. We have extensive experience in all of the above fields and are ready to help you today!

Book a meeting! 

Accreditations and Affiliations

image2
image3
image4
image5
image6
image7
image8
image8
image8